Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation 
Syntheia Signs Definitive Agreement for Call Center Acquisition 
CORRECTING and REPLACING Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification 
Wells Fargo Scandal Drove Borrowers to Fintech Lenders, UC Davis Study Suggests Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
AUSTIN, Texas, May 13, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company…
Uber Eats and Nimble Announce On-Demand Prescription Delivery in Seattle
Seattle consumers can now request prescription delivery directly in the Uber Eats app. Uber’s prescription…
Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
LA JOLLA, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage…
Y-mAbs Announces Update on SADA Technology
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021
Interim analysis from the ongoing, open-label, randomized acute viral pneumonia (including COVID-19) pilot study shows…
Uber Eats and Nimble Announce On-Demand Prescription Delivery in Washington, D.C.
District of Columbia consumers can now request prescription delivery directly in the Uber Eats app….
Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
LA JOLLA, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage…
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in…
Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021
Interim analysis from the ongoing, open-label, randomized acute viral pneumonia (including COVID-19) pilot study shows…
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
Recognition marks fourth consecutive year as top-ranked Phase I provider to work with; Company ranked among…
Auxly Announces $8.0 Million Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May…
ECMOHO Limited Announces the Appointment of Chief Financial Officer
SHANGHAI, China, May 13, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
Vericel to Present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20, 2021
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in…
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors
IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) — Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company”…
Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
CorMedix Inc. Announces Appointment of Chief Commercial Officer
Thomas Nusbickel to join CorMedix as Chief Commercial Officer; Brings significant experience in renal product…
Spero Therapeutics to Participate at the Berenberg Conference USA
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset…